We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.44B
AUM Growth
+$5.13M
Cap. Flow
-$60.9M
Cap. Flow %
-1.77%
Top 10 Hldgs %
13.68%
Holding
1,403
New
134
Increased
468
Reduced
577
Closed
124

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$7.91M
2
SBUX icon
Starbucks
SBUX
+$6.48M
3
CVS icon
CVS Health
CVS
+$6M
4
MDT icon
Medtronic
MDT
+$5.54M
5
WMT icon
Walmart Inc
WMT
+$5.12M

Sector Composition

Rank Sector Weight
1 Healthcare 12.56%
2 Financials 11.38%
3 Technology 10.34%
4 Industrials 9.82%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZBH icon
326
Zimmer Biomet
ZBH
$18.1B
$2.38M 0.07%
23,708
+17,937
+311% +$1.92M
UL icon
327
Unilever
UL
$137B
$2.37M 0.07%
51,683
+1,585
+3% +$73.9K
OKS
328
DELISTED
Oneok Partners LP
OKS
$2.36M 0.07%
54,958
-3,650
-6% -$151K
RHT
329
DELISTED
Red Hat Inc
RHT
$2.36M 0.07%
33,850
+100
+0.3% +$7.72K
ADI icon
330
Analog Devices
ADI
$179B
$2.36M 0.07%
32,453
-180
-0.6% -$12.2K
MAS icon
331
Masco
MAS
$14.2B
$2.35M 0.07%
74,261
-10,882
-13% -$349K
SDY icon
332
State Street SPDR S&P Dividend ETF
SDY
$21.8B
$2.34M 0.07%
27,394
-3,942
-13% -$331K
POT
333
DELISTED
Potash Corp Of Saskatchewan
POT
$2.34M 0.07%
129,112
-45,345
-26% -$786K
UNM icon
334
Unum
UNM
$13.6B
$2.33M 0.07%
53,153
+100
+0.2% +$4K
RQI icon
335
Cohen & Steers Quality Income Realty Fund
RQI
$1.7B
$2.33M 0.07%
190,918
+173
+0.1% +$2.06K
EVT icon
336
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.11B
$2.33M 0.07%
113,415
+3,772
+3% +$75.2K
NI icon
337
NiSource
NI
$21.4B
$2.33M 0.07%
105,093
-736
-0.7% -$16.4K
CYBR
338
DELISTED
CyberArk
CYBR
$2.33M 0.07%
51,108
+18,222
+55% +$889K
EG icon
339
Everest Group
EG
$14.5B
$2.29M 0.07%
10,596
+561
+6% +$116K
HASI icon
340
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.81B
$2.29M 0.07%
120,654
+2,723
+2% +$56.1K
HCA icon
341
HCA Healthcare
HCA
$86.8B
$2.28M 0.07%
30,787
-1,740
-5% -$130K
CG icon
342
Carlyle Group
CG
$16.4B
$2.27M 0.07%
148,824
+60,173
+68% +$929K
GDV icon
343
Gabelli Dividend & Income Trust
GDV
$2.6B
$2.27M 0.07%
113,154
+8,771
+8% +$170K
ES icon
344
Eversource Energy
ES
$27.3B
$2.27M 0.07%
41,001
+892
+2% +$47.7K
KR icon
345
Kroger
KR
$35.6B
$2.26M 0.07%
65,420
+13,249
+25% +$432K
KEY icon
346
KeyCorp
KEY
$24.3B
$2.24M 0.07%
122,769
+18,265
+17% +$288K
CLR
347
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$2.23M 0.06%
43,200
+2,500
+6% +$129K
KRE icon
348
State Street SPDR S&P Regional Banking ETF
KRE
$4.5B
$2.21M 0.06%
39,798
+6,024
+18% +$295K
FDX icon
349
FedEx
FDX
$73.1B
$2.21M 0.06%
11,866
-3,078
-21% -$565K
WR
350
DELISTED
Westar Energy Inc
WR
$2.2M 0.06%
39,071
+73
+0.2% +$4.15K

Similar funds

Oppenheimer & Co's Q4 2016 Portfolio in Review

As of Q4 2016, Oppenheimer & Co held 1,403 positions worth $3.44B, up 0.15% from $3.43B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q4 2016 filing shows 134 new, 468 increased, 577 reduced and 124 closed positions. Its largest new stake was Yum China: 126,647 shares worth $3.31M. The largest sale was Bank of America, an estimated $7.91M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Financials and Technology.

  • Oppenheimer & Co's largest Q4 2016 buy was Yum China: 126,647 shares worth $3.31M.
  • Oppenheimer & Co added most to Lumen in Q4 2016, an estimated $7.38M increase.
  • Oppenheimer & Co's biggest Q4 2016 reduction was Bank of America, cutting an estimated $7.91M.
  • Oppenheimer & Co fully exited iShares MBS ETF in Q4 2016, selling an estimated $3.35M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.44B portfolio in Q4 2016.
  • Oppenheimer & Co opened 134 new positions and closed 124 in Q4 2016.
  • Oppenheimer & Co's portfolio value rose 0.15% quarter-over-quarter to $3.44B.

Based on Oppenheimer & Co's 13F filing for Q4 2016, filed 2 Feb 2017.